Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Belite Bio(BLTE) the EBIT is -34.91 M (-98.38%), Beat estimate;the EPS is -0.7 (-40%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITExceed expectations
-0.03B98.38%
-0.04B100.46%
+0.00B2.08%
EPSExceed expectations
-0.740.00%
-0.805761.14%
+0.105721.14%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf